Phase II Trial of SBRT and Hormone Therapy for Oligometastases in Prostate Cancer

被引：2

作者：

Conde-Moreno, A. J. ^{[1
]}

Lopez, F. ^{[2
]}

Hervas, A. ^{[2
]}

Piquer Camanes, T. ^{[3
]}

Mendez, A. ^{[4
]}

Puertas, M. D. M. ^{[5
]}

Valero, J. J. ^{[6
]}

Gomez Iturriaga, A. ^{[7
]}

Rico, M. ^{[8
]}

Vazquez de la Torre, M. L. ^{[9
]}

Samper Ots, P. M. ^{[10
]}

Perez Romasanta, L. A. ^{[11
]}

Pastor Peidro, J. ^{[12
]}

Ibanez, C. ^{[13
]}

Ferrer, F. ^{[14
]}

Porras-Martinez, M. ^{[15
]}

Zapatero, A. ^{[16
]}

Garcia Blanco, A. S. ^{[17
]}

Rodriguez, A. ^{[18
]}

Ferrer, C. ^{[19
]}

机构：

[1] Hosp Univ & Politecn La Fe, Valencia, Spain

[2] Hosp Univ Ramon y Cajal, Madrid, Spain

[3] Consorcio Hosp Prov Castellon, Castellon de La Plana, Spain

[4] Miguel Servet Univ Hosp, Zaragoza, Spain

[5] Hosp Miguel Servet, Zaragoza, Spain

[6] Univ Hosp HM Sanchinarro Puerta del Sur, Madrid, Spain

[7] Cruces Univ Hosp, Baracaldo, Spain

[8] Complejo Hosp Navarra, Pamplona, Spain

[9] Hosp Meixoeiro, Vigo, Spain

[10] Hosp Univ Rey Juan Carlos, Madrid, Spain

[11] Hosp Clin Salamanca, Salamanca, Spain

[12] Hosp Gen Valencia, Valencia, Spain

[13] Hosp Cent Def Gomez Ulla, Madrid, Spain

[14] Catalan Inst Oncol, Dept Radiat Oncol, Lhospitalet Barcelona, Spain

[15] Hosp Univ Virgen de la Arrixaca, Murcia, Spain

[16] Hosp Univ La Princesa, Madrid, Spain

[17] Hosp Univ Marques de Valdecilla, Santander, Spain

[18] Hosp Ruber, Madrid, Spain

[19] Hosp Prov Castellon, Castellon de La Plana, Spain

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2019.06.155

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1075

引用

页码：S149 / S150

页数：2

共 50 条

[1] Phase II trial of SBRT and Hormone therapy for Oligometastases in Prostate Cancer (SBRT-SG 05).
Conde Moreno, A.
Lopez Campos, F.
Hervas Moron, A.
Vallejo Ocana, C.
Valero Albarran, J.
Mendez Villamon, A.
Puertas Valino, M.
Gomez-Iturriaga, A.
Samper Ots, P.
Sola Galarza, A.
Rico Oses, M.
Ibanez Villaoslada, C.
Perez-Romasanta, L. A.
Pastor Peidro, J.
Lopez-Torrecilla, J.
Ferrer Gonzalez, F.
Ortiz Rodil, N.
Garcia Pinon, F.
Rodriguez Perez, A.
Ferrer Albiach, C.
RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S27 - S28
[2] Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer
Conde-Moreno, A. J.
Lopez, F.
Hervas, A.
Morillo, V.
Mendez, A.
Puertas, M. D. M.
Valero Albarran, J.
Gomez De Iturriaga, A.
Rico, M.
Vazquez de la Torre, M. L.
Samper Ots, P. M.
Perez Romasanta, L. A.
Pastor Peidro, J.
Ibanez, C.
Ferrer, F.
Zapatero, A.
Anchuelo, J.
Rodriguez, A.
Albiach, C. F.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S59 - S59
[3] Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer: Trial in progress.
Conde Moreno, A.
Lopez Torrecilla, J.
Pastor Peidro, J.
Hervas Moron, A.
Lopez-Campos, F.
Mendez Villamon, A.
Puertas Valino, M. M.
Sola Galarza, A.
Rico Oses, M.
Samper Ots, P.
Perez-Romasanta, L. A.
Ibanez Villaoslada, C.
Valero Albarran, J.
Ortiz Rodil, N.
Garcia Pinon, F.
Ferrer Albiach, C.
RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S708 - S708
[4] A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05)
Conde-Moreno, Antonio J.
Lopez-Campos, Fernando
Hervas, Asuncion
Morillo, Virginia
Mendez, Agustina
Puertas, Maria D. M.
Valero-Albarran, Jeannette
Iturriaga, Alfonso Gomez
Rico, Mikel
Vazquez, Maria L.
Ots, Pilar M. Samper
Perez-Romasanta, Luis A.
Pastor, Jorge
Ibanez, Carmen
Ferrer, Ferran
Zapatero, Almudena
Garcia-Blanco, Ana S.
Rodriguez, Aurora
Ferrerc, Carlos
PRACTICAL RADIATION ONCOLOGY, 2024, 14 (05) : e344 - e352
[5] Phase II Trial of Definitive Therapy for Osseous Oligometastases in Breast Cancer
Marqueen, K. E.
Strom, E. A.
Ning, M. S.
Smith, B. D.
Tereffe, W.
Hoffman, K. E.
Stauder, M. C.
Perkins, G. H.
Buchholz, T. A.
Li, J.
McAleer, M. F.
Reddy, J.
Woodward, W. A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E136 - E136
[6] SBRT prostate cancer boost of 9 Gy, prospective phase II trial
Ferrer Gonzalez, F.
Pont, A.
De Blas, R.
Boladeras, A.
Garin, O.
Garcia Exposito, N.
Stefanovic, M.
Garcia Marqueta, M.
Juarez, M.
Olivas, M.
Armijos, L.
Alonso Becerra, M.
Alvarez, A.
Slocker, A.
Ventura, M.
Castells, M.
Merino, E.
Suarez, F.
Gutierrez, C.
Delgado, J.
Zardoya, E.
Najjari, D.
Picon, C.
Ferrer, M.
Guedea, F.
RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1091 - S1092
[7] A phase II trial of lapatinib in hormone refractory prostate cancer
Whang, Y. E.
Moore, C. N.
Armstrong, A. J.
Rathmell, W. K.
Godley, P. A.
Crane, J. M.
Grigson, G. I.
Morris, K.
Watkins, C. P.
George, D. J.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[8] Phase I/II clinical trial of gene therapy for hormone refractory metastatic prostate cancer
Gotoh, A
Terao, S
Shirakawa, T
JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 371 - 372
[9] Extreme hypofractionated SBRT for elderly prostate cancer patients: results of a phase II trial
Carbonara, R.
Gregucci, F.
Surgo, A.
Ciliberti, M. P.
Di Guglielmo, F. C.
Paulicelli, E.
Bonaparte, I.
Fiorentino, A.
RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1195 - S1195
[10] A Phase II Trial of Triamcinolone with Hormone Therapy for Prostate Cancer (TRICREST) in Chemotherapy Naive Metastatic Castration Resistant Prostate Cancer
Ng, K.
Sarker, S. -J.
Greenwood, M.
Gjafa, E.
Alifrangis, C.
Shamash, J.
CLINICAL ONCOLOGY, 2019, 31 (02) : E23 - E24

← 1 2 3 4 5 →